Is there any relationship between joint destruction and carotid intima-media thickness in patients with rheumatoid arthritis?

Journal of Physical Therapy Science

Volumn 26, Issue 7, 2014, Pages 1093-1096

  Tutoǧlu, Ahmet ^a   Boyaci, Ahmet ^a   Boyaci, Nurefsan ^b   Kaya, Zekeriya ^b   Aridici, Rifat ^a   Koca, Irfan ^c  

^a HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

^c GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Common carotid intima media thickness; Modified total sharp score; Rheumatoid arthritis

Indexed keywords

EID: 84905124555     PISSN: 09155287     EISSN: None     Source Type: Journal    
DOI: 10.1589/jpts.26.1093     Document Type: Article

References (31)

1. Galarza-Delgado DA, Esquivel-Valerio JA, Garza-Elizondo MA, et al.: Carotid atherosclerosis in patients with rheumatoid arthritis and rheumatoid nodules. Reumatol Clin, 2013, 9: 136-141.[Medline][CrossRef]
2. del Rincón ID, Williams K, Stern MP, et al.: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum, 2001, 44: 2737-2745.[Medline] [CrossRef]
3. Paksoy F, Ulas T, Namal E, et al.: Eosinophilic gastroenteritis associated with rheumatoid arthritis. Turk J Rheumatol, 2011, 26: 321-323.[Cross- Ref]
4. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR: Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol, 1997, 24: 445-451.[Medline]
5. Turesson C, McClelland RL, Christianson TJ, et al.: Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis, 2007, 66: 70-75.[Medline] [CrossRef]
6. Ridker PM, Rifai N, Rose L, et al.: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002, 347: 1557-1565.[Medline] [Cross- Ref]
7. Goodson NJ, Symmons DP, Scott DG, et al.: Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum, 2005, 52: 2293-2299.[Medline] [CrossRef]
8. Ridker PM, Hennekens CH, Roitman-Johnson B, et al.: Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet, 1998, 351: 88-92.[Medline] [CrossRef]
9. Van Doornum S, McColl G, Jenkins A, et al.: Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum, 2003, 48: 72-80.[Medline] [Cross- Ref]
10. Gkaliagkousi E, Gavriilaki E, Doumas M, et al.: Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management. J Clin Rheumatol, 2012, 18: 422-430.[Medline] [CrossRef]
11. Bots ML, Grobbee DE: Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther, 2002, 16: 341-351.[Medline] [CrossRef]
12. Chatterjee Adhikari M, Guin A, Chakraborty S, et al.: Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum, 2012, 41: 669-675.[Medline] [CrossRef]
13. Veselinovic MV, Zivkovic VI, Toncev S, et al.: Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis. Vasa, 2012, 41: 343-351.[Medline] [CrossRef]
14. Fries JF: Toward an understanding of patient outcome measurement. Arthritis Rheum, 1983, 26: 697-704.[Medline] [CrossRef]
15. Bukhari M, Harrison B, Lunt M, et al.: Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective communitybased study. Arthritis Rheum, 2001, 44: 1248-1253.[Medline] [CrossRef]
16. Welsing PM, van Gestel AM, Swinkels HL, et al.: The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum, 2001, 44: 2009-2017.[Medline] [CrossRef]
17. Drossaers-Bakker KW, de Buck M, van Zeben D, et al.: Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum, 1999, 42: 1854-1860.[Medline] [CrossRef]
18. Jamal S, Patra K, Keystone EC: Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysis. Clin Rheumatol, 2009, 28: 413-419.[Medline] [CrossRef]
19. De Cock D, Vanderschueren G, Meyfroidt S, et al.: Two-year clinical and radiologic follow-up of early RA patients treated with initial step up monotherapy or initial step down therapy with glucocorticoids, followed by a tight control approach: lessons from a cohort study in daily practice. Clin Rheumatol, 2014, 33: 125-130[CrossRef]. [Medline]
20. Arnett FC, Edworthy SM, Bloch DA, et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988, 31: 315-324.[Medline] [CrossRef]
21. Prevoo ML, van't Hof MA, Kuper HH, et al.: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum, 1995, 38: 44-48.[Medline] [CrossRef]
22. van der Heijde D: How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol, 2000, 27: 261-263.[Medline]
23. Ødegård S, Landewé R, van der Heijde D, et al.: Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis Rheum, 2006, 54: 68-75.[Medline] [CrossRef]
24. Kinosian B, Glick H, Garland G: Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med, 1994, 121: 641-647.[Medline] [CrossRef]
25. Peters MJ, Symmons DP, McCarey D, et al.: EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis, 2010, 69: 325-331.[Medline] [CrossRef]
26. O'Leary DH, Polak JF, Kronmal RA, et al.: Cardiovascular Health Study Collaborative Research Group: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med, 1999, 340: 14-22.[Medline] [CrossRef]
27. Polak JF, Pencina MJ, Pencina KM, et al.: Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med, 2011, 365: 213-221.[Medline] [CrossRef]
28. Naredo E, Möller I, Corrales A, et al.: Automated radiofrequency-based US measurement of common carotid intima-media thickness in RA patients treated with synthetic vs synthetic and biologic DMARDs. Rheumatology (Oxford), 2013, 52: 376-381.[Medline] [CrossRef]
29. Turiel M, Tomasoni L, Sitia S, et al.: Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis. Cardiovasc Ther, 2010, 28: e53-e64.[Medline] [CrossRef]
30. Lorenz MW, von Kegler S, Steinmetz H, et al.: Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke, 2006, 37: 87-92.[Medline] [CrossRef]
31. Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A, et al.: High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol, 2005, 32: 1219-1223.[Medline]